Potential Risk of Hypoglycemia in Patients with Heart Failure

Yasushi Teshima1, Ryosuke Shiga1, Shotaro Saito1

  • 1Department of Cardiology and Clinical Examination, Faculty of Medicine, Oita University.

Insights

Patients with chronic heart failure experience prolonged hypoglycemia, even without diabetes treatment. This study highlights the risk of low blood glucose in heart failure patients, suggesting malabsorption as a potential cause.

Area of Science:

  • Endocrinology
  • Cardiology
  • Metabolic Disorders

Background:

  • Glucose metabolism alterations in chronic heart failure are not well understood.
  • Previous research has not focused on sequential interstitial glucose changes in non-diabetic heart failure patients.

Purpose of the Study:

  • To investigate sequential interstitial glucose concentration changes in patients with chronic heart failure (CHF).
  • To compare glucose profiles between CHF patients and those with chronic heart disease but no heart failure, excluding antidiabetic therapy.

Main Methods:

  • Utilized a continuous glucose monitoring device (FreeStyle Libre Pro) for 1-week monitoring.
  • Enrolled 11 patients with CHF (Heart failure (+)) and 7 controls (Heart failure (-)).
  • Analyzed interstitial glucose levels, including average, peak, duration of hyperglycemia (≥ 140 mg/dL), and hypoglycemia (< 80 mg/dL).

Main Results:

  • No significant differences in average glucose, peak values, or hyperglycemia duration between groups.
  • Significantly longer duration and lower trough values of hypoglycemia in the Heart failure (+) group.
  • Prolonged hypoglycemia observed predominantly from midnight to morning in Heart failure (+) patients, often without subjective symptoms.

Conclusions:

  • Patients with chronic heart failure are at increased risk of hypoglycemia, independent of antidiabetic treatment.
  • Malabsorption is a potential contributing mechanism for hypoglycemia in this population.
  • Continuous glucose monitoring reveals significant nocturnal hypoglycemia in heart failure patients.

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
679
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
595
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
319
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.5K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
157
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
134